| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Krzysztof Szyfter | Q22114906 |
| Katarzyna Kiwerska | Q59159574 | ||
| P2860 | cites work | Double-strand break repair-adox: Restoration of suppressed double-strand break repair during mitosis induces genomic instability | Q26991670 |
| Targeting DNA damage response in cancer therapy | Q27023204 | ||
| p53 coordinates base excision repair to prevent genomic instability | Q28834500 | ||
| The cancer genome | Q29547643 | ||
| Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes | Q33596701 | ||
| DNA damage response--a double-edged sword in cancer prevention and cancer therapy | Q34454975 | ||
| DNA repair gene variants in relation to overall cancer risk: a population-based study | Q36499747 | ||
| Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. | Q36710840 | ||
| Overexpression of DNA repair genes is associated with metastasis: a new hypothesis | Q37097570 | ||
| Platinum resistance: the role of DNA repair pathways | Q37100598 | ||
| Cancers exhibit a mutator phenotype: clinical implications | Q37165106 | ||
| DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis | Q37977244 | ||
| DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease | Q38563227 | ||
| Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer | Q38659673 | ||
| Removal of oxidatively generated DNA damage by overlapping repair pathways | Q39000410 | ||
| Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance | Q39454681 | ||
| Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy | Q41636798 | ||
| Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity | Q42244844 | ||
| Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects | Q43547587 | ||
| Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers | Q44767574 | ||
| Repairing DNA for 80 years: the timeline of my life | Q46114897 | ||
| The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma | Q46140928 | ||
| Radiation-induced unrepairable DSBs: their role in the late effects of radiation and possible applications to biodosimetry | Q49557385 | ||
| Reduced expression of mismatch repair genes MSH6/MSH2 directly promotes pituitary tumor growth via the ATR-Chk1 pathway | Q50000976 | ||
| DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma. | Q51281400 | ||
| Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression. | Q52589171 | ||
| Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. | Q52607320 | ||
| Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients | Q57177355 | ||
| Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea | Q57481863 | ||
| Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients | Q57486087 | ||
| Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma | Q57818008 | ||
| Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma | Q58802064 | ||
| rs1799782 (C194T) polymorphism correlated with tumor metastasis and molecular subtypes in breast cancer | Q60049551 | ||
| Polymorphism of DNA repair genes in breast cancer | Q61796811 | ||
| Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response | Q61805942 | ||
| A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer | Q84372981 | ||
| Association of C722T polymorphism in XRCC3 gene with larynx cancer: a meta-analysis | Q87283567 | ||
| Inherent and toxicant-provoked reduction in DNA repair capacity: A key mechanism for personalized risk assessment, cancer prevention and intervention, and response to therapy | Q90449251 | ||
| The Clinical Impact of the Genomic Landscape of Mismatch Repair-Deficient Cancers | Q93159717 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dysplasia | Q1128996 |
| neoplasm DNA | Q71515340 | ||
| P304 | page(s) | 329-334 | |
| P577 | publication date | 2019-08-30 | |
| 2019-11-01 | |||
| P1433 | published in | Journal of Applied Genetics | Q15767059 |
| P1476 | title | DNA repair in cancer initiation, progression, and therapy-a double-edged sword | |
| P478 | volume | 60 |
| Q109919922 | Cancer as a prospective sequela of long COVID‐19 | cites work | P2860 |
Search more.